401 related articles for article (PubMed ID: 25656443)
1. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus.
Bou R; Adán A; Borrás F; Bravo B; Calvo I; De Inocencio J; Díaz J; Escudero J; Fonollosa A; de Vicuña CG; Hernández V; Merino R; Peralta J; Rúa MJ; Tejada P; Antón J
Rheumatol Int; 2015 May; 35(5):777-85. PubMed ID: 25656443
[TBL] [Abstract][Full Text] [Related]
2. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
Arthritis Rheumatol; 2019 Jun; 71(6):864-877. PubMed ID: 31021511
[TBL] [Abstract][Full Text] [Related]
3. Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.
Yamazaki S; Shimbo A; Akutsu Y; Takase H; Morio T; Mori M
Pediatr Rheumatol Online J; 2020 Mar; 18(1):26. PubMed ID: 32293465
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.
Heiligenhaus A; Klotsche J; Tappeiner C; Sengler C; Niewerth M; Liedmann I; Hoeft S; Walscheid K; Lavric M; Foell D; Minden K
Rheumatology (Oxford); 2019 Jun; 58(6):975-986. PubMed ID: 30590748
[TBL] [Abstract][Full Text] [Related]
5. Juvenile idiopathic arthritis-associated uveitis.
Sen ES; Ramanan AV
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):517-534. PubMed ID: 29773271
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW;
Trials; 2014 Jan; 15():14. PubMed ID: 24405833
[TBL] [Abstract][Full Text] [Related]
7. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
Arthritis Care Res (Hoboken); 2019 Jun; 71(6):703-716. PubMed ID: 31021540
[TBL] [Abstract][Full Text] [Related]
8. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Henderson LA; Zurakowski D; Angeles-Han ST; Lasky A; Rabinovich CE; Lo MS;
Pediatr Rheumatol Online J; 2016 Feb; 14(1):9. PubMed ID: 26879972
[TBL] [Abstract][Full Text] [Related]
9. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.
Constantin T; Foeldvari I; Anton J; de Boer J; Czitrom-Guillaume S; Edelsten C; Gepstein R; Heiligenhaus A; Pilkington CA; Simonini G; Uziel Y; Vastert SJ; Wulffraat NM; Haasnoot AM; Walscheid K; Pálinkás A; Pattani R; Györgyi Z; Kozma R; Boom V; Ponyi A; Ravelli A; Ramanan AV
Ann Rheum Dis; 2018 Aug; 77(8):1107-1117. PubMed ID: 29592918
[TBL] [Abstract][Full Text] [Related]
10. Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
Cecchin V; Zannin ME; Ferrari D; Pontikaki I; Miserocchi E; Paroli MP; Bracaglia C; Marafon DP; Pastore S; Parentin F; Simonini G; De Libero C; Falcini F; Petaccia A; Filocamo G; De Marco R; La Torre F; Guerriero S; Martino S; Comacchio F; Muratore V; Martini G; Vittadello F; Zulian F
J Rheumatol; 2018 Aug; 45(8):1167-1172. PubMed ID: 29657140
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
Ramanan AV; Dick AD; Jones AP; McKay A; Williamson PR; Compeyrot-Lacassagne S; Hardwick B; Hickey H; Hughes D; Woo P; Benton D; Edelsten C; Beresford MW;
N Engl J Med; 2017 Apr; 376(17):1637-1646. PubMed ID: 28445659
[TBL] [Abstract][Full Text] [Related]
12. Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.
Heiligenhaus A; Minden K; Tappeiner C; Baus H; Bertram B; Deuter C; Foeldvari I; Föll D; Frosch M; Ganser G; Gaubitz M; Günther A; Heinz C; Horneff G; Huemer C; Kopp I; Lommatzsch C; Lutz T; Michels H; Neß T; Neudorf U; Pleyer U; Schneider M; Schulze-Koops H; Thurau S; Zierhut M; Lehmann HW
Semin Arthritis Rheum; 2019 Aug; 49(1):43-55. PubMed ID: 30595409
[TBL] [Abstract][Full Text] [Related]
13. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
Deitch I; Amer R; Tomkins-Netzer O; Habot-Wilner Z; Friling R; Neumann R; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series.
La Torre F; Cattalini M; Teruzzi B; Meini A; Moramarco F; Iannone F
BMC Res Notes; 2014 May; 7():316. PubMed ID: 24886032
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab for juvenile idiopathic arthritis-associated uveitis.
Magli A; Forte R; Navarro P; Russo G; Orlando F; Latanza L; Alessio M
Graefes Arch Clin Exp Ophthalmol; 2013 Jun; 251(6):1601-6. PubMed ID: 23446556
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
[TBL] [Abstract][Full Text] [Related]
17. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
19. Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?
Mastrangelo G; Foeldvari I; Anton J; Simonini G
Pediatr Rheumatol Online J; 2019 Jul; 17(1):40. PubMed ID: 31296236
[TBL] [Abstract][Full Text] [Related]
20. Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
Leinonen ST; Aalto K; Kotaniemi KM; Kivelä TT
Clin Exp Rheumatol; 2017; 35(6):1043-1046. PubMed ID: 29148422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
